Physician profile
Sami Moshi
NPI 1922349547
$24,553.12
in general payments reported to CMS, 2019-2025
78 companies · $5,265 in 2025
The $5,265 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,404 · 2020: $1,590 · 2021: $2,804 · 2022: $5,057 · 2023: $3,523 · 2024: $4,910 · 2025: $5,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,572.30 |
| Education | $126.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,726.18 | 2021-2025 | |
| Ucb, INC. | $2,289.50 | 2019-2025 | Fintepla, Zilbrysq, Briviact |
| Biogen, INC. | $1,447.28 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Sk Life Science, INC. | $908.44 | 2021-2025 | Xcopri |
| Neurocrine Biosciences, INC. | $859.81 | 2021-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $855.40 | 2020-2025 | Kisunla, Emgality, Amyvid |
| Mdd US Operations, LLC | $820.07 | 2023-2025 | Gocovri, Qelbree, Gocovri |
| Genzyme Corporation | $787.56 | 2019-2025 | |
| Eisai INC. | $723.64 | 2020-2025 | |
| Amgen INC. | $704.40 | 2019-2025 | Uplizna, Tepezza |
| Alexion Pharmaceuticals, INC. | $702.22 | 2019-2025 | Ultomiris, Strensiq, Soliris |
| Amneal Pharmaceuticals LLC | $689.84 | 2021-2025 | Rytary, Crexont, Ongentys |
| Emd Serono, INC. | $643.13 | 2019-2025 | Mavenclad |
| Acadia Pharmaceuticals INC | $595.56 | 2021-2025 | Nuplazid |
| Pfizer INC. | $593.62 | 2023-2025 |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $541.18 | 2021-2025 | |
| Livanova USA, INC. | $463.20 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Allergan, INC. | $460.83 | 2020-2022 | |
| Neurelis, INC. | $437.74 | 2020-2025 | Valtoco |
| Biohaven Pharmaceutical Holding Company LTD. | $421.12 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $381.57 | 2023-2025 | Rexulti, Nuedexta |
| Teva Pharmaceuticals USA, INC. | $363.16 | 2019-2025 | Austedo Xr, Austedo Xr |
| Argenx US, INC. | $356.72 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Jazz Pharmaceuticals INC. | $346.72 | 2022-2025 | Epidiolex |
| Aucta Pharmaceuticals, INC. | $323.93 | 2024-2025 | Motpoly Xr |
| Sanofi-Aventis U.S. LLC | $316.22 | 2019-2025 | |
| Impel Pharmaceuticals INC. | $310.44 | 2022-2023 | Trudhesa |
| Celgene Corporation | $306.24 | 2021-2024 | Zeposia |
| Genentech USA, INC. | $300.05 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.31 | 2019-2024 | Jardiance |
| Lundbeck LLC | $243.23 | 2021-2025 | Rexulti |
| Adamas Pharmaceuticals, INC. | $226.05 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $220.01 | 2022-2025 | Xeomin, Inbrija |
| Janssen Pharmaceuticals, INC | $198.63 | 2022-2025 | Spravato |
| Janssen Biotech, INC. | $172.57 | 2025 | |
| Ge Healthcare | $161.44 | 2022-2025 | |
| Avanir Pharmaceuticals, INC. | $157.91 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $145.05 | 2023-2025 | Hyqvia |
| Horizon Therapeutics Plc | $135.70 | 2022-2023 | Uplizna |
| Biohaven Pharmaceuticals, INC. | $121.99 | 2021 | |
| Supernus Pharmaceuticals, INC. | $119.14 | 2021-2022 | |
| Kedrion Biopharma, INC. | $107.10 | 2024-2025 | Koate, Kedrab, Gammaked |
| Kyowa Kirin, INC. | $106.65 | 2022-2024 | Nourianz, Crysvita |
| Banner Life Sciences, LLC | $104.61 | 2022-2024 | |
| Tanabe Pharma America, INC. | $77.44 | 2024-2025 | Radicava |
| Vanda Pharmaceuticals INC. | $76.47 | 2024-2025 | Hetlioz, Fanapt |
| Ani Pharmaceuticals, INC. | $75.40 | 2022-2025 | Purified Cortrophin Gel |
| Acorda Therapeutics, INC | $74.95 | 2022-2023 | Ampyra, Inbrija |
| Grifols USA, LLC | $71.21 | 2023-2025 | Gamunex-C |
| Mannkind Corporation | $71.11 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.44 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $59.67 | 2022-2023 | Firdapse |
| Becton, Dickinson and Company | $57.72 | 2021-2022 | |
| Corcept Therapeutics | $54.35 | 2025 | Korlym |
| Novo Nordisk INC | $51.71 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $50.44 | 2020-2021 | |
| Csl Behring | $47.19 | 2023-2025 | Hizentra |
| Sumitomo Pharma America, INC. | $46.83 | 2023 | Aptiom |
| Abbott Laboratories | $45.94 | 2021-2024 | Infinity |
| Akcea Therapeutics, INC. | $45.33 | 2019 | |
| Averitas Pharma INC. | $42.44 | 2023-2024 | Qutenza |
| Greenwich Biosciences, INC. | $41.07 | 2021 | |
| Octapharma USA, INC. | $40.38 | 2023-2024 | Panzyga |
| Tg Therapeutics, INC. | $34.05 | 2025 | |
| Cequr Corporation | $32.39 | 2022-2023 | Cequr Simplicity |
| Biotissue Holdings INC. | $22.97 | 2022 | |
| Medtronic, INC. | $22.34 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.49 | 2025 | Zonisade |
| Cala Health, INC. | $21.21 | 2023 | Cala Trio, Cala Kiq |
| Axsome Therapeutics, INC. | $17.59 | 2025 | Symbravo |
| Rgh Enterprises LLC | $16.38 | 2025 | |
| Dexcom, INC. | $16.33 | 2021 | |
| Merz North America, INC. | $15.80 | 2019 | |
| Impel Pharmaceuticals LLC | $15.74 | 2024 | Trudhesa |
| Xeris Pharmaceuticals, INC. | $15.64 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.05 | 2024 | |
| Microtransponder, INC. | $14.04 | 2025 | |
| Idorsia Pharmaceuticals US INC | $12.85 | 2023 | Quviviq |
Drugs and devices associated with these payments
Qulipta $1,011Ubrelvy $878Gocovri $720Fintepla $659Ingrezza $619Vumerity $611Tysabri $541Rexulti $525Nurtec Odt $510Zavzpret $455Leqembi $429Botox $421Ultomiris $393Zilbrysq $342Epidiolex $325Valtoco $325Motpoly Xr $324Vns Therapy Sentiva Model 1000 Generator $314Nuplazid $261Briviact $254Rytary $245Zeposia $243Uplizna $242Vyvgart Hytrulo $227Mavenclad $203Nayzilam $192Kisunla $184Ongentys $181Kesimpta $158Trudhesa $157Emgality $145Xeomin $131Paxlovid $127Hyqvia $114Rhogam Ultra-Filtered Plus $107Koate $107Albuked $107Kedrab $107Gammaked $107Amyvid $106Ocrevus $103Panzyga $95.05Jardiance $92.93Strensiq $91.75Qelbree $89.67Radicava $77.44Hetlioz $76.47Fanapt $76.47Gamunex-C $71.21Rystiggo $66.63Enspryng $65.60Kerendia $61.44Inbrija $61.07Korlym $54.35Comirnaty $54.14Duopa $53.27Soliris $53.15Purified Cortrophin Gel $50.54Bafiertam $49.85Aubagio $49.10Nourianz $48.72Hizentra $47.19Aptiom $46.83Tzield $44.37Ocrevus Zunovo $43.56Firdapse $43.31Qutenza $42.44Vraylar $40.43Tepezza $37.69Xcopri $36.11Vyalev $34.51Briumvi $34.05Vyvgart $32.61Mounjaro $29.81Austedo Xr $27.48Radicava Ors $26.84Zepbound $25.88Spravato $25.42Fycompa $23.96Crysvita $22.24Infinity $22.01Zonisade $21.49Skyclarys $21.40Cala Kiq $21.21Cala Trio $21.21Ampyra $21.19Reyvow $20.70Avonex $19.91Plegridy $19.91Cequr Simplicity $18.21Symbravo $17.59Mayzent $17.19Nuedexta $15.51Ztlido $14.05Crexont $13.50Quviviq $12.85Apokyn $10.16
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Moshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.